RxVantage

RxVantage

RxVantage is transforming the way physicians and their staff receive education about the latest medical breakthroughs and technology, directly from the companies that develop them.
Our apps intelligently connect healthcare providers with the precise life sciences experts that they need, when they need it, in a manner that fits seamlessly into their workflow. As a result, medical practices are able to keep physicians and staff up to date on the latest medical technology, without wasting valuable time coordinating these educational visits.
RxVantage has powered over 5,000,000 educational exchanges between healthcare providers, their staff, and life science experts. In doing so, our free platform has helped medical practices access more targeted education, which ultimately benefits patients.

Desma Caputo,
Arizona Oncology - Biltmore Cancer Center

• SpecialtyOncology
• 125+ Providers & Staff
• Improved meeting quality

“Reps help our practice stay up-to-date on new medications, utilization, side effects and patient assistance programs.
With RxVantage, we get this information without having to spend time scheduling and managing it. This is really important for us."

Investment - Spectrum Equity and McKesson Ventures

We’re pleased to announce our latest investment, led by Spectrum Equity and McKesson Ventures. These investors join our existing team which includes dRx Capital (Novartis), Merck Global Health Innovation Fund, Javelin Venture Partners and Slater Technology Fund.
RxVantage’s core technology enables healthcare professionals and life science experts to partner effortlessly, securely and seamlessly so medical practices can get the resources they need, exactly when and where they need them. This investment comes after a tremendous period of organic growth at RxVantage, during which we’ve welcomed more than 2,500 leading medical practices to our network, grown to over 55,000 active life science experts, and expanded to over 70 direct partnerships with life sciences companies. We’ve also added more than 100 amazing people to the RxV team, organically and via the acquisition of onPoint oncology, and we will more than double the team again in the coming months.
We’re proud of what we’ve achieved and are even more excited about the future. The rapid pace of innovation in medical technology and the ever-increasing complexity of treatment protocols require healthcare professionals and life science companies to partner more efficiently and effectively than ever before. Our “provider-first” approach powers these partnerships, increasingly through virtual engagements on our platform, and helps elevate the practice of medicine for providers, life sciences, and patients.
In short, we are powering smarter connections.
Each day, our team works tirelessly on behalf of our community of healthcare and life sciences professionals to deliver these smarter connections and build our community. They are truly world-class and we are grateful for their hard work and dedication. This new funding will help us accelerate our vision by bringing more doctors and medical practices into our network and delivering new innovations that meet the evolving needs of our extraordinary community.
We are excited to welcome Spectrum Equity and McKesson Ventures as investors and partners. Moreover, we are excited to further our mission and find new ways to support our provider and life science communities amidst unprecedented disruptions and new engagement models.
Source: https://www.rxvantage.com/